Skip to content

Cormorant Asset Management, LP: DRUG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Cormorant Asset Management, LP on DRUG, newest first. How the timeline and the estimate are built.

Cormorant Asset Management, LP held 800,000 DRUG shares at 2026-09-30 per its 13F-HR filed 2026-11-16.

no 13D/G or Form 3/4/5 step is dated after the latest 13F period 2026-09-30

  1. event date2026-09-30
    13G/A 800,000 shares
    Share basis changed not comparable

    8.11% of the class. Different basis (group aggregate from 13G/A).

    13G/A 0001172661-26-005294 filed by Cormorant Asset Management, LP
    Accepted , ingested

    A 13D/G states the aggregate of its reporting persons, which may include entities that do not file a 13F.

  2. period ended2026-09-30
    13F 800,000 shares
    Change vs previous 13F -100,000 shares

    2.68% of the 13F portfolio, value $39,856,000.

    13F-HR 0001583977-26-000011 filed by Cormorant Asset Management, LP
    Accepted , ingested

  3. period ended2026-06-30
    13F 900,000 shares
    Change vs previous 13F -159,331 shares

    3.24% of the 13F portfolio, value $63,180,000.

    13F-HR 0001583977-26-000007 filed by Cormorant Asset Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2026-03-31
    13F 1,059,331 shares
    Change vs previous 13F 0 shares

    3.9% of the 13F portfolio, value $77,299,383.

    13F-HR 0001583977-26-000002 filed by Cormorant Asset Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-12-31
    13F 1,059,331 shares
    Change vs previous 13F 0 shares

    4.69% of the 13F portfolio, value $82,670,191.

    13F-HR 0001583977-26-000001 filed by Cormorant Asset Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-09-30
    13F 1,059,331 shares
    Change vs previous 13F 0 shares

    4.43% of the 13F portfolio, value $64,259,018.

    13F-HR 0001583977-25-000011 filed by Cormorant Asset Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2025-06-30
    13F 1,059,331 shares
    Change vs previous 13F 0 shares

    2.06% of the 13F portfolio, value $27,659,132.

    13F-HR 0001583977-25-000007 filed by Cormorant Asset Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2025-03-31
    13F 1,059,331 shares
    Change vs previous 13F 0 shares

    2.89% of the 13F portfolio, value $38,210,069.

    13F-HR 0001583977-25-000005 filed by Cormorant Asset Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  9. period ended2024-12-31
    13F 1,059,331 shares
    Change vs previous 13F not available

    2.1% of the 13F portfolio, value $38,157,103.

    13F-HR 0001583977-25-000001 filed by Cormorant Asset Management, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).